Ethanol enhances JWH-018-induced impairment of sensorimotor and memory functions in mice: From preclinical evidence to forensic implication in Driving Under the Influence of Drugs.

[1]  R. Giorgetti,et al.  Psychomotor performances relevant for driving under the combined effect of ethanol and synthetic cannabinoids: A systematic review , 2023, Frontiers in Psychiatry.

[2]  A. Giorgetti,et al.  Gender differences in driving under the influence of psychoactive drugs: Evidence mapping of real case studies and meta-analysis. , 2022, Forensic science international.

[3]  R. Giorgetti,et al.  Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving , 2022, Frontiers in Psychiatry.

[4]  K. Varani,et al.  In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice , 2022, International journal of molecular sciences.

[5]  E. Chan,et al.  Transesterification of Indazole-3-Carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarker for Diagnosing Co-Abuse of 5F-MDMB-PINACA and Alcohol. , 2021, Journal of analytical toxicology.

[6]  F. De-Giorgio,et al.  Ethanol enhanced MDPV- and cocaine-induced aggressive behavior in mice: Forensic implications. , 2021, Drug and alcohol dependence.

[7]  A. Giorgetti,et al.  Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications , 2021, Life.

[8]  M. Neri,et al.  Comparison of N-methyl-2-pyrrolidone (NMP) and the “date rape” drug GHB: behavioral toxicology in the mouse model , 2021, Psychopharmacology.

[9]  J. Ramaekers,et al.  Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users , 2021, Pharmacology Biochemistry and Behavior.

[10]  K. Tomiyama,et al.  Synthetic cannabinoids enhanced ethanol-induced motor impairments through reduction of central glutamate neurotransmission. , 2020, Toxicology and applied pharmacology.

[11]  H. Richardson,et al.  Sex Differences in the Neurobiology of Alcohol Use Disorder , 2020, Alcohol research : current reviews.

[12]  H. Lee,et al.  In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters , 2020, Molecules.

[13]  L. Fattore,et al.  Sex and Gender Differences in the Effects of Novel Psychoactive Substances , 2020, Brain sciences.

[14]  H. Teixeira,et al.  The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review , 2020, Critical reviews in toxicology.

[15]  R. Giorgetti,et al.  Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists , 2020, Frontiers in Psychiatry.

[16]  J. Lappin,et al.  Characteristics and circumstances of synthetic cannabinoid-related death , 2020, Clinical toxicology.

[17]  M. Liechti,et al.  Designer drugs: mechanism of action and adverse effects , 2020, Archives of Toxicology.

[18]  K. Tamama,et al.  Newly Emerging Drugs of Abuse. , 2019, Handbook of experimental pharmacology.

[19]  David R. Williams,et al.  The epidemiology of alcohol use disorders cross-nationally: Findings from the World Mental Health Surveys. , 2019, Addictive behaviors.

[20]  S. V. Kachin,et al.  Types of synthetic cannabinoids seized from illicit trafficking in the territory of the Siberian Federal District (Russia) between 2009-2018. , 2019, Forensic science international.

[21]  Eunyoung Han,et al.  A review of drug abuse in recently reported cases of driving under the influence of drugs (DUID) in Asia, USA, and Europe. , 2019, Forensic Science International.

[22]  K. Kaneda,et al.  Effects of the synthetic cannabinoid 5F-AMB on anxiety and recognition memory in mice , 2019, Psychopharmacology.

[23]  P. Adamowicz,et al.  Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA , 2019, Clinical toxicology.

[24]  H. Gjerde,et al.  Association between alcohol and drug use and arrest for driving under the influence after crash involvement in a rural area of Norway: a case–control study , 2019, BMJ Open.

[25]  Ju-Hyun Kim,et al.  Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes , 2018, Archives of Pharmacal Research.

[26]  A. Weinstein,et al.  Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective , 2018, Front. Public Health.

[27]  S. Đorđević,et al.  Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids , 2018, Arhiv za higijenu rada i toksikologiju.

[28]  N. Samyn,et al.  Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs population. , 2018, Drug Testing and Analysis.

[29]  M. Huestis,et al.  Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review. , 2017, Journal of analytical toxicology.

[30]  G. Gessa,et al.  Sex Differences in Alcohol Use Disorder. , 2017, Current medicinal chemistry.

[31]  V. Lelong-Boulouard,et al.  Focus on cannabinoids and synthetic cannabinoids , 2017, Clinical pharmacology and therapeutics.

[32]  C. Trapella,et al.  Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence , 2016, Neuropharmacology.

[33]  L. Vinay,et al.  Early postnatal maturation in vestibulospinal pathways involved in neck and forelimb motor control , 2016, Developmental neurobiology.

[34]  M. Thevis,et al.  In vitro elucidation of the metabolic profile of the synthetic cannabinoid receptor agonists JWH-175 and JWH-176 , 2016, Forensic Toxicology.

[35]  Shery Jacob,et al.  A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.

[36]  C. Trapella,et al.  JWH-018 impairs sensorimotor functions in mice , 2015, Neuroscience.

[37]  S. V. Malheiros,et al.  A review on alcohol: from the central action mechanism to chemical dependency. , 2015, Revista da Associacao Medica Brasileira.

[38]  B. Winters,et al.  Intraperirhinal cortex administration of the synthetic cannabinoid, HU210, disrupts object recognition memory in rats , 2015, Neuroreport.

[39]  Matt Anderson,et al.  European Monitoring Centre for Drugs and Drug Addiction , 2014 .

[40]  G. Silberberg,et al.  Multisensory Integration in the Mouse Striatum , 2014, Neuron.

[41]  S. Toennes,et al.  Retrospective analysis of synthetic cannabinoids in serum samples--epidemiology and consumption patterns. , 2014, Forensic science international.

[42]  D. E. López,et al.  Origin and function of short-latency inputs to the neural substrates underlying the acoustic startle reflex , 2014, Front. Neurosci..

[43]  D. Qiu,et al.  Ethanol attenuates sensory stimulus-evoked responses in cerebellar granule cells via activation of GABAA receptors in vivo in mice , 2014, Neuroscience Letters.

[44]  B. Basavarajappa,et al.  CB1 receptor‐mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH‐081, a new component of spice/K2 preparations , 2014, Hippocampus.

[45]  B. Logan,et al.  Blood synthetic cannabinoid concentrations in cases of suspected impaired driving. , 2013, Journal of analytical toxicology.

[46]  T. L. Martin,et al.  A Review of Alcohol‐Impaired Driving: The Role of Blood Alcohol Concentration and Complexity of the Driving Task , 2013, Journal of forensic sciences.

[47]  P. Prather,et al.  Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. , 2013, Toxicology and applied pharmacology.

[48]  L. Wise,et al.  Detection and disposition of JWH-018 and JWH-073 in mice after exposure to "Magic Gold" smoke. , 2012, Forensic science international.

[49]  Kathryn A. Seely,et al.  A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors. , 2012, Chemical research in toxicology.

[50]  Kathleen E. Cullen,et al.  The vestibular system: multimodal integration and encoding of self-motion for motor control , 2012, Trends in Neurosciences.

[51]  A. Schneir,et al.  Convulsions Associated with the Use of a Synthetic Cannabinoid Product , 2012, Journal of Medical Toxicology.

[52]  R. Morris,et al.  Spatial characterization of the motor neuron columns supplying the rat forelimb , 2012, Neuroscience.

[53]  M. Antunes,et al.  The novel object recognition memory: neurobiology, test procedure, and its modifications , 2011, Cognitive Processing.

[54]  T. Tzounopoulos,et al.  Mechanisms underlying input-specific expression of endocannabinoid-mediated synaptic plasticity in the dorsal cochlear nucleus , 2011, Hearing Research.

[55]  W. Fratta,et al.  Beyond THC: The New Generation of Cannabinoid Designer Drugs , 2011, Front. Behav. Neurosci..

[56]  William E. Fantegrossi,et al.  Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity , 2011, PloS one.

[57]  C. Kang,et al.  Three cases of “spice” exposure , 2011, Clinical toxicology.

[58]  A. Ennaceur.  One-trial object recognition in rats and mice: Methodological and theoretical issues , 2010, Behavioural Brain Research.

[59]  Adi Ronen,et al.  The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks. , 2010, Accident; analysis and prevention.

[60]  Per Magne Knutsen,et al.  Cannabinoids reveal separate controls for whisking amplitude and timing in rats. , 2010, Journal of neurophysiology.

[61]  M. Baxter.  "I've seen it all before": explaining age-related impairments in object recognition. Theoretical comment on Burke et al. (2010). , 2010, Behavioral neuroscience.

[62]  Yung-Ching Liu,et al.  Effects of Different Blood Alcohol Concentrations and Post-Alcohol Impairment on Driving Behavior and Task Performance , 2010, Traffic injury prevention.

[63]  S. Patel,et al.  Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex , 2010, British journal of pharmacology.

[64]  N. Ferreirós,et al.  'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? , 2009, Journal of mass spectrometry : JMS.

[65]  Asaf Keller,et al.  Superior colliculus control of vibrissa movements. , 2008, Journal of neurophysiology.

[66]  Adi Ronen,et al.  Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol. , 2008, Accident; analysis and prevention.

[67]  C. Vorhees,et al.  Alterations in Body Temperature, Corticosterone, and Behavior Following the Administration of 5-Methoxy-Diisopropyltryptamine (‘Foxy’) to Adult Rats: a New Drug of Abuse , 2007, Neuropsychopharmacology.

[68]  L. Trussell,et al.  Coactivation of Pre- and Postsynaptic Signaling Mechanisms Determines Cell-Specific Spike-Timing-Dependent Plasticity , 2007, Neuron.

[69]  L. Petrocellis,et al.  Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain , 2006, Neuroscience.

[70]  S. Salvadori,et al.  Blockade of Nociceptin/Orphanin FQ Transmission Attenuates Symptoms and Neurodegeneration Associated with Parkinson's Disease , 2005, The Journal of Neuroscience.

[71]  J. Crabbe,et al.  Scheduled access to ethanol results in motor impairment and tolerance in female C57BL/6J mice , 2005, Pharmacology Biochemistry and Behavior.

[72]  L. Padgett,et al.  Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. , 2005, Current medicinal chemistry.

[73]  A. Verstraete,et al.  Drugs and Driving , 2004, Traffic injury prevention.

[74]  K. Hargreaves,et al.  The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat , 2003, Neuroscience.

[75]  C. Hillard,et al.  The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat , 2002, Neuroscience Letters.

[76]  D. Bereiter,et al.  Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat , 2002, Pain.

[77]  T. Järvinen,et al.  Cannabinoids in the treatment of glaucoma. , 2002, Pharmacology & therapeutics.

[78]  H. Moskowitz,et al.  A review of the literature on the effects of low doses of alcohol on driving-related skills , 2000 .

[79]  K. Mackie,et al.  Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[80]  D. Deutsch,et al.  Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina , 1999, The Journal of comparative neurology.

[81]  G. Marsicano,et al.  Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain , 1999, The European journal of neuroscience.

[82]  K. Mackie,et al.  Localization of cannabinoid CB1 receptors in the human anterior eye and retina. , 1999, Investigative ophthalmology & visual science.

[83]  K. Mackie,et al.  Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system , 1998, Neuroscience.

[84]  Marc Jamon,et al.  Role of gravity in the development of posture and locomotion in the neonatal rat , 1998, Brain Research Reviews.

[85]  A. Akaike,et al.  Ethanol reduces spontaneous firing and potentiates GABA-induced currents in acutely dissociated rat medial vestibular nucleus neurons. , 1998, Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence.

[86]  I. Hindmarch,et al.  The effects of alcohol alone or in combination with other drugs on information processing, task performance and subjective responses , 1998 .

[87]  P. Best,et al.  Comparison between the effects of ethanol and diazepam on spatial working memory in the rat , 1997, Psychopharmacology.

[88]  B. Givens,et al.  Effects of ethanol on nonspatial working memory and attention in rats. , 1997, Behavioral neuroscience.

[89]  J. Aggleton,et al.  Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix , 1997, Experimental Brain Research.

[90]  B. Givens,et al.  Behavioral correlates of single units in the medial septal area: The effect of ethanol , 1996, Neuroscience.

[91]  S. Fox,et al.  The suppressant effect of ethanol, delivered via intrahippocampal microdialysis, on the firing of local pyramidal cells in freely behaving rats. , 1995, Alcohol.

[92]  B. Givens,et al.  Ethanol suppresses the induction of long-term potentiation in vivo , 1995, Brain Research.

[93]  B. Givens.  Low doses of ethanol impair spatial working memory and reduce hippocampal theta activity. , 1995, Alcoholism, clinical and experimental research.

[94]  R. Ritzmann,et al.  A low dose of ethanol impairs working memory in mice in a win-shift foraging paradigm. , 1993, Alcohol.

[95]  A. Ennaceur,et al.  A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs. non-spatial working memory , 1992, Behavioural Brain Research.

[96]  D Sleet,et al.  Alcohol and driving: is the 0.05% blood alcohol concentration limit justified? , 1991, Drug and alcohol review.

[97]  M. Herkenham,et al.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[98]  E. Landau,et al.  Long-term potentiation in rat hippocampus is inhibited by low concentrations of ethanol , 1990, Brain Research.

[99]  A. Ciociola,et al.  Teratogenic and Behavioral Anomalies Induced by Acute Exposure of Mice to Ethanol and Their Possible Relation to Fetal Brain DNA Synthesis , 1988, Pharmaceutical Research.

[100]  M. Eckardt,et al.  Response to ethanol reduced by past thiamine deficiency. , 1985, Science.

[101]  M. Neri,et al.  Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice. , 2019, Neurotoxicology.

[102]  V. Vindenes,et al.  Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids. , 2015, Forensic science international.

[103]  V. Vindenes,et al.  Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period. , 2014, Accident; analysis and prevention.

[104]  Burkhard Madea,et al.  Driving under the influence of synthetic cannabinoids (“Spice”): a case series , 2013, International Journal of Legal Medicine.

[105]  N. Freedman,et al.  Brain imaging study of the acute effects of Δ9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana , 2007, Psychopharmacology.

[106]  P. Best,et al.  Ethanol, memory, and hippocampal function: A review of recent findings , 2000, Hippocampus.

[107]  S. Yoshida,et al.  Effects of ethanol on vestibular nucleus neurons responding to sinusoidal rotation. , 1987, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.